Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323

Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, Yoshio Tsunezuka, Nobuhiko Seki, Toshiyuki Harada, Nobukazu Fujimoto, Akihiro Bessho, Kei Takamura, Kazuhisa Takahashi, Miyako Satouchi, Terufumi Kato, Takehito Shukuya, Natsumi Yamashita, Hiroaki Okamoto, Tetsu Shinkai, Thoracic Oncology Research Group